legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

# Prime Medicine, Inc.

## Introduction
Prime Medicine, Inc., a biotechnology company focused on developing revolutionary gene editing therapies, recently presented new preclinical data for PM359, demonstrating the potential of Prime Editors to correct genetic mutations effectively. With plans to enter clinical development in 2024, Prime Medicine is set to make significant strides in genetic therapy with initial data expected in 2025. Additionally, Prime Medicine Co-Founder, David Liu, Ph.D., was honored with the ASGCT Outstanding Achievement Award.

## Events and Presentations
Prime Medicine is set to highlight its Prime Editing technology and ongoing programs at key industry events such as the 3rd Annual LNP Formulation and Process Development Summit, the ASGCT 27th Annual Meeting, and TIDES USA Oligonucleotide & Peptide Therapeutics Conference. These presentations will showcase the company’s progress and advancements in gene editing technology.

### 3rd Annual LNP Formulation and Process Development Summit (Boston)

### American Society of Cell & Gene Therapy (ASGCT) 27th Annual Meeting (Baltimore)
– **Presentation Name:** Development and Delivery of Prime Editors
– **Date & Time:** Tuesday, May 7, 2024, 9:45 a.m. ET
– **Presenter:** Jonathan Levy, Ph.D.
– **Poster Name:** Exon Reframing by Prime Editors Restores Dystrophin
– **Date & Time:** Wednesday, May 8, 2024, 12:00 p.m. ET
– **Presenter:** Michelle O’Connor, Ph.D.
– **Presentation Name:** Development of a Prime Edited CD34+ cell Drug Product for the Treatment of P47phox Chronic Granulomatous Disease
– **Date & Time:** Wednesday, May 8, 2024, 5:15 p.m. ET
– **Presenter:** Jennifer Gori, Ph.D.
– **Presentation Name:** Off-Target Analysis Shows Favorable Safety Profile of Prime Editing
– **Date & Time:** Friday, May 10, 2024, 2:45 p.m. ET
– **Presenter:** Maria Collier, Ph.D.
– **Presentation Name:** Prime Editors Precisely Correct Pathogenic RHO Mutations and Preserve Photoreceptors In Vivo
– **Date & Time:** Wednesday, May 8, 2024, 3:45 p.m. ET
– **Presenter:** Deepak Reyon, Ph.D.

### TIDES USA Oligonucleotide & Peptide Therapeutics Conference (Boston)
– **Workshop:** Introduction to Genome Editing
– **Date & Time:** Tuesday, May 14, 2024, 9:00 a.m. ET
– **Presenter:** Jeffrey Hussman, Ph.D.
– **Presentation Name:** Gene Editing, Regulatory and Delivery Challenges and Perspectives
– **Date & Time:** Tuesday, May 14, 2024, 4:15 p.m. ET
– **Presenter:** Luis Santos, Ph.D.
– **Presentation Name:** RNA-Based Approach to Delivering Prime Editing
– **Date & Time:** Thursday, May 16, 2024, 10:45 a.m. ET
– **Presenter:** Seth Alexander, Ph.D.
– **Presentation Name:** Analytical Development for Prime Editing Guide (peg)RNAs
– **Date & Time:** Friday, May 17, 2024, 11:45 a.m. ET
– **Presenter:** Xiangkun Yang, Ph.D.

## About Prime Medicine
Prime Medicine is at the forefront of gene editing therapies, utilizing its proprietary Prime Editing platform to develop curative genetic treatments. The company’s versatile technology offers potential for widespread genetic mutation correction across various diseases. With a diverse portfolio of therapeutic programs, Prime Medicine aims to address unmet medical needs and expand its reach beyond genetic diseases.

## How AI legalese decoder Can Help
The AI legalese decoder can assist Prime Medicine in navigating the complex legal and regulatory landscape associated with gene editing technologies. By using AI to decode legal jargon and streamline compliance processes, Prime Medicine can ensure adherence to industry regulations and effectively protect its intellectual property rights. This tool can enhance efficiency in legal operations and support Prime Medicine’s mission to advance gene editing therapies for the benefit of patients worldwide.

## Conclusion
Prime Medicine’s commitment to groundbreaking gene editing technology and innovative therapies positions the company as a leader in the field. With upcoming presentations and ongoing advancements, Prime Medicine is poised to revolutionize genetic therapies and make a lasting impact on the future of healthcare.

—
[Image Source](https://s.yimg.com/ny/api/res/1.2/QbE.bwtItqkUXS41YHUFiA–/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MA–/https://ml.globenewswire.com/media/ZGE3MTM3NDQtYjMxYi00OTk2LTgwMTItOGYzNWNhZTUyZWYwLTEyNDU1NzE=/tiny/Prime-Medicine-Inc-.png)

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link